Biogen has bagged $250 million to advance a key pipeline prospect. | Biogen has bagged $250 million to advance a key pipeline ...

The funding agreement comes as Biogen revealed a modest Q4 sales beat, which analysts expect will be “overshadowed” by the ...

The agreement hands Biogen as much as $250 million in exchange for milestone payments and sales royalties for litifilimab, which is in a pair of late-stage studies in lupus.

People with lupus are at an increased risk of depression. Lupus is a chronic condition with recurring symptoms that can ...

Genentech has shared positive data from the Phase III REGENCY trial with regulators in the US and EU. Roche’s subsidiary ...

Biogen Inc. CEO Christopher Viehbacher gave investors an overview of what type of deals the company is looking for Wednesday ...

The event raised awareness for those with lupus, a chronic autoimmune disease that leads the body’s immune system to attack ...

Gazyva/Gazyvaro (obinutuzumab) was found to significantly improve complete renal response in lupus nephritis patients, ...

Lung cancer cases are increasing in people who have never smoked, especially in women, a new study by the World Health ...

Biogen posted strong Q4 results, surpassing estimates, while forecasting a 2025 revenue decline. The company secured up to ...

The Lupus Foundation of America is a nonprofit whose mission is to "improve the quality of life for all people affected by ...

Competition leaders the Saitama Wild Knights and defending champions Brave Lupus Tokyo played to a gripping 28-28 deadloc ...